Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Epinephrine Lidocaine products are in shortage in Canada (2 of 9 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 15, 2027.
A local anesthetic combined with epinephrine used to numb tissue during medical and dental procedures.
Products affected
2 / 9
In shortage since
Apr 1, 2026
Est. full return
Jun 15, 2027
Reports on file
66
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
DIN 01901915 · ended Dec 4, 2024 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 2% W EPINEPHRINE 1:200000
5MCG
20MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00284106 · ended Sep 3, 2024 · Disruption of the manufacture of the drug.
Avoided
XYLOCAINE 1% W EPINEPHRINE 1:200000
5MCG
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00001805 · ended Jul 10, 2024 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 2% WITH EPINEPHRINE 1:200000
0.005MG
20MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02373130 · ended Jun 24, 2024 · Delay in shipping of the drug.
Avoided
XYLOCAINE 1% W EPINEPHRINE 1:100000
0.01MG
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00001791 · ended Jun 14, 2024 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 2% W EPINEPHRINE 1:200000
5MCG
20MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00284106 · ended Feb 6, 2024 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 1% W EPINEPHRINE 1:100000
0.01MG
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00001791 · ended Feb 6, 2024 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 1% W EPINEPHRINE 1:200000
5MCG
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00001805 · ended Jan 1, 2024 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 2% WITH EPINEPHRINE 1:200000
0.005MG
20MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02373130 · ended Jan 3, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Epinephrine Lidocaine is currently affected by 2 active shortage reports filed with Health Canada by PFIZER CANADA ULC, TELIGENT OU.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Epinephrine Lidocaine is classified under “ANESTHETICS, LOCAL” (ATC N01BB).
Recent changes
No changes recorded yet.
Common questions
What is Epinephrine Lidocaine used for?
A local anesthetic combined with epinephrine used to numb tissue during medical and dental procedures.
When will Epinephrine Lidocaine be back in stock in Canada?
The latest manufacturer estimate is Jun 15, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Epinephrine Lidocaine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.